Asp was found to antagonize liver fibrosis by inhibiting HSC proliferation and activation and boosting cell apoptosis and to block the NF-κB/NLRP3 inflammasome signaling pathway in HSCs by upregulating the expression of NS3TP1. Here, ASNSD1 is linked to Hepatic fibrosis.